Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs

Biochimie

Volumn 125, Issue , 2016, Pages 297-305

  Carrière, Frédéric ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

Drug delivery; In vitro digestion; Lipase; Lipids; Lipolysis; o w emulsions

Indexed keywords

ACYLGLYCEROL; ALPHA TOCOPHEROL; CYCLOSPORIN A; DANAZOL; DRUG; FATTY ACID; GRISEOFULVIN; IBUPROFEN; LIPID; LIPOPHILIC DRUG; MACROGOL; PHOSPHOLIPID; POLYSORBATE; PROBUCOL; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; DIGESTION; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG INDUSTRY; DRUG SOLUBILITY; LIPOLYSIS; MAXIMUM PLASMA CONCENTRATION; PRECIPITATION; REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION; ANIMAL; CHEMISTRY; GASTROINTESTINAL ABSORPTION; HUMAN; INTESTINE; METABOLISM; PROCEDURES; STOMACH;

ANIMALS; DRUG DELIVERY SYSTEMS; GASTROINTESTINAL ABSORPTION; HUMANS; INTESTINES; LIPIDS; LIPOLYSIS; STOMACH;

EID: 84968752858     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2015.11.016     Document Type: Review

References (44)

1. A. Mullard 2014 FDA drug approvals Nat. Rev. Drug Discov. 14 2015 77 81
2. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
3. D.J. Hauss Oral Lipid-based Formulations: Enhancing the Bioavailability of Poorly Water-soluble Drugs vol. 170 2007 Taylor & Francis, Inc. New York 368 p.
4. C.J. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248
5. J.C. Bakala N'Goma, S. Amara, K. Dridi, V. Jannin, and F. Carriere Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems Ther. Deliv. 3 2012 105 124
6. H.D. Williams, M.U. Anby, P. Sassene, K. Kleberg, J.C. Bakala-N'goma, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, F. Carriere, A. Mullertz, C.W. Pouton, and C.J. Porter Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion Mol. Pharm. 9 2012 3286 3300
7. H.D. Williams, P. Sassene, K. Kleberg, J.C. Bakala-N'Goma, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, F. Carriere, A. Mullertz, C.J. Porter, and C.W. Pouton Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations J. Pharm. Sci. 101 2012 3360 3380
8. H.D. Williams, P. Sassene, K. Kleberg, M. Calderone, A. Igonin, E. Jule, J. Vertommen, R. Blundell, H. Benameur, A. Mullertz, C.J. Porter, and C.W. Pouton Toward the establishment of standardized in vitro tests for lipid-based formulations, part 4: proposing a new lipid formulation performance classification system J. Pharm. Sci. 103 2014 2441 2455
9. H.D. Williams, P. Sassene, K. Kleberg, M. Calderone, A. Igonin, E. Jule, J. Vertommen, R. Blundell, H. Benameur, A. Mullertz, C.W. Pouton, and C.J. Porter Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations Pharm. Res. 30 2013 3059 3076
10. P. Sassene, K. Kleberg, H.D. Williams, J.C. Bakala-N'Goma, F. Carriere, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, C.J. Porter, C.W. Pouton, and A. Mullertz Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels AAPS J. 16 2014 1344 1357
11. J.C. Bakala-N'Goma, H.D. Williams, P.J. Sassene, K. Kleberg, M. Calderone, V. Jannin, A. Igonin, A. Partheil, D. Marchaud, E. Jule, J. Vertommen, M. Maio, R. Blundell, H. Benameur, A. Mullertz, C.W. Pouton, C.J. Porter, and F. Carriere Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase Pharm. Res. 32 2015 1279 1287
12. C.W. Pouton Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 29 2006 278 287
13. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S93 S98
14. S.A. Charman, W.N. Charman, M.C. Rogge, T.D. Wilson, F.J. Dutko, and C.W. Pouton Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound Pharm. Res. 9 1992 87 93
15. D.Q.M. Craig, H.S.R. Lievens, K.G. Pitt, and D.E. Storey An investigation into the physicochemical properties of self-emulsifying systems using low-frequency dielectric-spectroscopy, surface-tension measurements and particle size analysis Int. J. Pharm. 96 1993 147 155
16. C.W. Pouton Formulation of self-emulsifying drug delivery system Adv. Drug Deliv. Rev. 25 1997 47 58
17. D. Fleisher, C. Li, Y. Zhou, L.H. Pao, and A. Karim Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications Clin. Pharmacokinet. 36 1999 233 254
18. E.A. Mueller, J.M. Kovarik, J.B. van Bree, J. Grevel, P.W. Lucker, and K. Kutz Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation Pharm. Res. 11 1994 151 155
19. S.M. Khoo, D.M. Shackleford, C.J. Porter, G.A. Edwards, and W.N. Charman Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs Pharm. Res. 20 2003 1460 1465
20. S.M. Caliph, W.N. Charman, and C.J. Porter Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats J. Pharm. Sci. 89 2000 1073 1084
21. A. Larsen, R. Holm, M.L. Pedersen, and A. Mullertz Lipid-based formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis Pharm. Res. 25 2008 2769 2777
22. J.T. Lo, B.H. Chen, T.M. Lee, J. Han, and J.L. Li Self-emulsifying O/W formulations of paclitaxel prepared from mixed nonionic surfactants J. Pharm. Sci. 99 2010 2320 2332
23. I.-M. Chu, T.-R. Wang, US Patent 6348491: Oil-in-water emulsion for encapsulating paclitaxel., (2002).
24. F.S. Nielsen, K.B. Petersen, and A. Mullertz Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state Eur. J. Pharm. Biopharm. 69 2008 553 562
25. D.H. Truong, T.H. Tran, T. Ramasamy, J.Y. Choi, H.H. Lee, C. Moon, H.G. Choi, C.S. Yong, and J.O. Kim Development of solid self-emulsifying formulation for improving the oral bioavailability of erlotinib AAPS PharmSciTech 2015 10.1208/s12249-015-0370-5 PMID: 26238806
26. E.A. Mueller, J.M. Kovarik, J.B. van Bree, W. Tetzloff, J. Grevel, and K. Kutz Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation Pharm. Res. 11 1994 301 304
27. T. Julianto, K.H. Yuen, and A.M. Noor Improved bioavailability of vitamin E with a self emulsifying formulation Int. J. Pharm. 200 2000 53 57
28. F. Carrière, J.A. Barrowman, R. Verger, and R. Laugier Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans Gastroenterology 105 1993 876 888
29. S. Fernandez, V. Jannin, J.D. Rodier, N. Ritter, B. Mahler, and F. Carriere Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters Biochim. Biophys. Acta 1771 2007 633 640
30. S. Fernandez, J.D. Rodier, N. Ritter, B. Mahler, F. Demarne, F. Carriere, and V. Jannin Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases Biochim. Biophys. Acta 1781 2008 367 375
31. A.T. Larsen, P. Sassene, and A. Müllertz In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems Int. J. Pharm. 417 2011 245 255
32. A. Dahan, and A. Hoffman Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats Pharm. Res. 23 2006 2165 2174
33. G. Benzonana, and P. Desnuelle Kinetic study of the action of pancreatic lipase on emulsified triglycerides. Enzymology assay in heterogeneous medium Biochim. Biophys. Acta 105 1965 121 136
34. V. Delorme, R. Dhouib, S. Canaan, F. Fotiadu, F. Carriere, and J.F. Cavalier Effects of surfactants on lipase structure, activity, and inhibition Pharm. Res. 28 2011 1831 1842
35. A. Aloulou, J.A. Rodriguez, S. Fernandez, D. Van Oosterhout, D. Puccinelli, and F. Carriere Exploring the specific features of interfacial enzymology based on lipase studies Biochim. Biophys. Acta - Mol. Cell Biol. Lipids 1761 2006 995 1013
36. J.F. Cuine, W.N. Charman, C.W. Pouton, G.A. Edwards, and C.J. Porter Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs Pharm. Res. 24 2007 748 757
37. F. Carrière, Y. Gargouri, H. Moreau, S. Ransac, E. Rogalska, and R. Verger Gastric lipases: cellular, biochemical and kinetic aspects P. Wooley, S.B. Petersen, Lipases: Their Structure, Biochemistry and Application 1994 Cambridge University Press Cambridge, England 181 205
38. Y. Gargouri, G. Piéroni, C. Rivière, J.-F. Saunière, P.A. Lowe, L. Sarda, and R. Verger Kinetic assay of human gastric lipase on short- and long-chain triacylglycerol emulsions Gastroenterology 91 1986 919 925
39. H. Moreau, Y. Gargouri, D. Lecat, J.-L. Junien, and R. Verger Purification, characterization and kinetic properties of the rabbit gastric lipase Biochim. Biophys. Acta 960 1988 286 293
40. F. Carrière, H. Moreau, V. Raphel, R. Laugier, C. Bénicourt, J.-L. Junien, and R. Verger Purification and biochemical characterization of dog gastric lipase Eur. J. Biochem. 202 1991 75 83
41. S. Fernandez, S. Chevrier, N. Ritter, B. Mahler, F. Demarne, F. Carrière, and V. Jannin In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14 Pharm. Res. 26 2009 1901 1910
42. S. Fernandez, V. Jannin, S. Chevrier, Y. Chavant, F. Demarne, and F. Carriere In vitro digestion of the self-emulsifying lipid excipient labrasol((R)) by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate Pharm. Res. 30 2013 3077 3087
43. F. Carriere, C. Renou, V. Lopez, J. De Caro, F. Ferrato, H. Lengsfeld, A. De Caro, R. Laugier, and R. Verger The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals Gastroenterology 119 2000 949 960
44. C.J. Porter, C.W. Pouton, J.F. Cuine, and W.N. Charman Enhancing intestinal drug solubilisation using lipid-based delivery systems Adv. Drug Deliv. Rev. 60 2008 673 691